This empirically-derived information is intended to help both consumers and physicians determine the best course of interventional treatment. Review the risks and benefits of different Interventional Orthopedic treatments based upon our in-house research studies.
If you’re using 3-5X PRP in tendons you may be under dosing certain patients.
Two articles have been published suggesting that higher concentrations of PRP cause tenocyte inhibition. Given that both studies had serious design flaws, Interventional Orthopedics Foundation (IOF) scientists repeated these experiments.
By Dustin Berger, M.S. Platelets are small cell fragments within our blood that play important roles in the wound healing process. In addition to being responsible for stopping blood flow at a site of injury, platelets are loaded full of beneficial growth factors....read more
A reference for information regarding placental derived products. This data includes company follow-up and statements / responses to our December 16, 2015 press release regarding an absence of stem cells in placental tissue-derived products.read more
BROOMFIELD, Colo.--(BUSINESS WIRE)--The Interventional Orthopedics Foundation (IOF), a 501c3 non-profit dedicated to providing education about regenerative orthopedic medicine, recently announced the results of independent lab tests showing an absence of live stem...read more
As presented at the First Annual Interventional Orthopedics Foundation Conference on October 23rd, here is a link to view our latest research poster "In Vitro Evaluation of Injectable, Placental Tissue-Derived Products for Orthopedic Applications". This scientific...read more